Meet our team
Psychiatrist-in-Chief
Massachusetts General Hospital (MGH)
​
Executive Director, MGH Clinical Trials Network and Institute
​
Associate Dean for Clinical and Translational Research, Harvard Medical School
​
Slater Family Professor of Psychiatry, Harvard Medical School
​
​
President and Founder
Learned Consulting Group, LLC​
​
SVP, Global Medicines Development
Indivior, Inc. (2015-2021)
VP, Medicines Dev and other roles including:
Head, Neurosciences Discovery Medicine during development of Zyban® (bupropion) and Radafaxine (S,S-hydroxybupropion),
GlaxoSmithKline (1997-2015)
Director, Center for Depression, Anxiety and Stress Research
Director, Laboratory for Translational and Affective Neuroscience
Director of Research, Division of Depression & Anxiety Disorders
Director, McLean Imaging Center
McLean Hospital
​
Professor of Psychiatry
Harvard Medical School
Chair, CSO, and Founder, RIFFIT, Inc.
​
Board Member and Advisor, DeuteRx, LLC
​
CSO, Rhythm Pharmaceuticals (2011-2019)
​
SVP, Integrative Medicine & Translational Science, Abraxis Biosciences (2009-2011)
Head, R&D, Abraxis Health
​
Site Head and VP Research
Merck Research Labs – Boston (2004-2008)
Founder and/or Officer: Covectra, Inc., Senticare, Inc. (Acquired by Rx Advance); Adherence Technologies, Inc.; PharmoRx Therapeutics, Inc.; Ergot BioSciences
​
Professor of Psychiatry, University of Massachusetts Medical Center (1988-1992)
​
Chairman of Psychiatry, University of Massachusetts Memorial Hospital (1988-1992)
​
Co-Founder and First Psychiatric Director, Behavioral Neurology Unit, Beth Israel Hospital, Harvard Medical School (1978-1982)